Prevention of Rh immunisation during the first half of pregnancy;Forebyggelse af rhesusimmunisering: I. Teoretisk baggrund og imødegåelse af risiko i første halvdel af graviditeten

Ugeskrift for Laeger

Volumn 166, Issue 36, 2004, Pages 3073-3078

  Falck Larsen, Jørgen ^a   Bock, Johannes E ^a   Jørgensen, Jan R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; RHESUS D ANTIBODY; RHESUS D ANTIGEN;

AMNIOCENTESIS; CHORION VILLUS SAMPLING; DRUG INDICATION; ECTOPIC PREGNANCY; FETOMATERNAL TRANSFUSION; FIRST TRIMESTER PREGNANCY; HUMAN; HYDATIDIFORM MOLE; IMMINENT ABORTION; IMMUNOPROPHYLAXIS; PRACTICE GUIDELINE; REVIEW; RHESUS ISOIMMUNIZATION; RISK MANAGEMENT;

ABORTION, INDUCED; ABORTION, SPONTANEOUS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; PRACTICE GUIDELINES; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PREGNANCY, ECTOPIC; RH ISOIMMUNIZATION; RHO(D) IMMUNE GLOBULIN; RISK FACTORS;

EID: 4444304538     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Meddelelse af 6.XI.1969 fra Sundhedsstyrelsen ti landets læger og sygehuse angående behandling af Rhesus-negative kvinder med anti-D immunoglobulin. Ugeskr Læger 1969;131:1968.
2. Tabor A, Bock JE, Jacobsen JC. Rhesus-immunisering.. Ugeskr Læger 1982;144:3093-5.
3. Royal College of Obstetricians and Gynaecologists. Use of Anti-D Immunoglobulin for Rh profylaxis. Green Top Guidelines. Revised May 2002. www.rcog.org.uk/guidelines/ maj 2004.
4. American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin: Prevention of Rh D alloimmunization. May 1999. Intern J Gynecol Obstet 1999;66:63-70.
5. Falck Larsen J, Bock JE, Jørgensen J. Forebyggelse af rhesus-immunisering. II. Imoødegåelse af risiko i anden halvdel af graviditeten. Ugeskr Læger 2004;166:3078-83.
6. Jakobowicz R, Williams L, Silberman F. Immunization of Rh-negative volunteers by repeated injections of very small amounts of Rh-positive blood. Vox Sang 1972;23:376-81.
7. Bowman JM, Pollock JM, Penston LE. Fetomaternal transplacental hemorrhage during pregnancy and after delivery. Vox Sang 1986;51:117-21.
8. Jørgensen J. Foèto-maternel blødning [disp]. Århus: eget forlag, 1976.
9. Matthews CD, Matthews AEB. Transplacental haemorrhage in spontaneous and induced abortion. Lancet 1969;i:694-5.
10. Murray S, Barron SL, McNay RA. Transplacental haemorrhage after abortion. Lancet 1970;i:631-4.
11. Freda VJ, Gorman JG, Galen RS et al. The treat of Rh immunisation from abortion. Lancet 1970;ii:147-8.
12. Queenan JT, Gadow EC, Lopes AC. Role of spontaneous abortion in Rh immunization. Am J Obstet Gynecol 1971;110:128-30.
13. Bergstrom H, Nilsson LA, Nilsson L et al. Demonstration of Rh antigens in a 38-day-old fetus. Am J Obstet Gynecol 1967;99:130-3.
14. Von Stein GA, Munsick RA, Stiver K et al. Fetomaternal hemorrhage in threatened abortion. Obstet Gynecol 1992;79:383-6.
15. McSweeney E, Kirkham J, Vinall P et al. An audit of anti-D sensitisation in Yorkshire. Br J Obstet Gynaecol 1998;105:1091-4.
16. Liedholm P. Feto-maternal haemorrhage in ectopic pregnancy. Acta Obstet Gynecol Scand 1971;50:367-8.
17. Voigt JC, Britt RP. Feto-maternal haemorrhage in therapeutic abortion. BMJ 1969;4:395-6.
18. Queenan JT, Kubarych SF, Shah S et al. Role of induced abortion in rhesus immunisation. Lancet 1971;1:815-7.
19. Urquhart DR, Templeton A. Reduced risk of isoimmunisation in medical abortion. Lancet 1990;335:914.
20. Warren RC, Butler J, Morsman JM et al. Does chorionic villus sampling cause fetomaternal haemorrhage? Lancet 1985;1:691.
21. Smidt-Jensen S, Philip J, Zachary JM et al. Implications of maternal serum alpha-fetoprotein elevation caused by transabdominal and transcervical CVS. Prenat Diagn 1994;14:35-45.
22. Smidt-Jensen S, Bock JE. Choronic villus sampling and rhesusimmunization. I. Marec M, Ferguson-Smith MA, eds. Proceeding Conference on Early Fetal Diagnosis: Recent progress and public health implications. Prague: Karolinum-Charles University Press, 1992:166-9.
23. Thomsen SG, Isager-Sally L, Lange AP et al. Elevated maternal serum alpha-fetoprotein caused by midtrimester amniocentesis: a prognostic factor. Obstet Gynecol 1983;62:297-300.
24. Blajchman MA, Maudsley RF, Uchida I et al. Diagnostic amniocentesis and fetal-maternal bleeding. Lancet 1974;1:993-4.
25. Bowman JM, Pollock JM. Transplacental fetal hemorrhage after amniocentesis. Obstet Gynecol 1985;66:749-54.
26. Hansen KB, Nussler E, Jørgensen J. Komplikationer ved amniocentese i 2. trimester. Ugeskr Læger 1980;142:760-2.
27. Tabor A, Jerne D, Bock JE. Incidence of rhesus immunisation after genetic amniocentesis. BMJ (ClinResEd) 1986;293:533-6.
28. Golbus MS, Stephens JD, Cann HM et al. Rh isoimmunization following genetic amniocentesis. Prenat Diagn 1982;2:149-56.
29. Murray JC, Karp LE, Williamson RA et al. Rh isoimmunization related to amniocentesis. Am J Med Genet 1983;16:527-34.
30. Hill LM, Platt LD, Kellogg B. Rh sensitization after genetic amniocentesis. Obstet Gynecol 1980;56:459-61.
31. Queenan JT, Schneider J. Practical clinical aspects of RH-prophylaxis. J Perinat Med 1973;1:223-34.
32. Power JP, Davidson F, O'Riordan J et al. Hepatitis C infection from anti-D immunoglobulin. Lancet 1995;346:372-3.
33. National Institute for Clinical Excellence, U. K. Guidance on the use of routine antenatal anti-D profylaxis for RhD-negative women. Technical Appraisal No. 41. May 2002. www.nice.org.uk/maj 2004.
34. Pollack W, Ascari WQ, Kochesky RJ et al. Studies on Rh prophylaxis. 1. Relationship between doses of anti-Rh and size of antigenic stimulus. Transfusion 1971;11:333-9.
35. Pollack W, Ascari WQ, Crispen JF et al. Studies on Rh prophylaxis. II. Rh immune prophylaxis after transfusion with Rh-positive blood. Transfusion 1971;11:340-4.
36. WHO. Prevention of Rh-sensitization. Technicical Report Series 468. Geneva: WHO, 1971.
37. Lee D, Contreras M, Robson SC et al. Recommendations for the use of anti-D immunoglobulin for Rh prophylaxis. British Blood Transfusion Society and the Royal College of Obstetricians and Gynaecologists. Transfus Med 1999;9:93-7.
38. Fiala C, Fux M, Gemzell K. Rh-prophylaxis in early abortion. Acta Obstet Gynecol Scand. 2003;82:892-903.
39. Messeter L. Rh-prophylax eller ej? Läkartidningen 2000;97:6030-3.
40. Lind J. Ingen nya råd om Rh-immunisering. Läkartidningen 2000;97:1011.